| [1] |
非酒精性脂肪性肝病防治指南(2018年更新版) 临床肝胆病杂志,2018, 34: 947-957.
|
| [2] |
He X, Ji G, Jia W, et al. Gut microbiota and nonalcoholic fatty liver disease: insights on mechanism and application of metabolomics . Int J Mol Sci, 2016, 17: 300.
|
| [3] |
Abdou RM, Zhu L, Baker RD, et al. Gut microbiota of nonalcoholic fatty liver disease . Dig Dis Sci, 2016, 61: 1268-1281.
|
| [4] |
Abdul-Hai A, Abdallah A, Malnick SD. Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease . World J Hepatol, 2015, 7: 1679-1684.
|
| [5] |
Doulberis M, Kotronis G, Gialamprinous D, et al. Non-alcoholic fatty liver disease: an update with special focus on the role of gut microbiota . Metabolism, 2017, 71:182-197.
|
| [6] |
Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD) . Metabolism, 2016, 65: 1038-1048.
|
| [7] |
Usami M, Miyoshi M, Yamashita H. Gut microbiota and host metabolism in liver cirrhosis . World J Gastroenterol, 2015, 21: 11597-11608.
|
| [8] |
Sherriff JL, O′Sullivan TA, Properzi C, et al. Choline, its potential role in nonalcoholic fatty liver disease, and the case for human and bacterial genes . Adv Nutr, 2016, 7: 5-13.
|
| [9] |
Jiang C, Xie C, Li F, et al. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease . J Cli Invest, 2015, 125: 386-402.
|
| [10] |
Chen YM, Liu Y, Zhou RF, et al. Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults . Sci Rep, 2016, 6:19076.
|
| [11] |
Neuman MG, French SW, Zakhari S, et al. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage . Exp Mol pathol, 2017, 102: 162-180.
|
| [12] |
Zhu L, Baker SS, Gill C, et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology, 2013, 57: 601-609.
|
| [13] |
Manco M. Insulin resistance and nafld: a dangerous liaison beyond the genetics . Children (Basel), 2017, 4:74.
|
| [14] |
Wong VW, Won GL, Chim AM, et al. Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study . Ann Hepatol, 2013, 12: 256-262.
|
| [15] |
Alisi A, Bedogni G, Baviera G, et al. Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis . Aliment Pharmaco Ther, 2014, 39: 1276-1285.
|
| [16] |
Famouri F, Shariat Z, Hashemipour M, et al. Effects of probiotics on nonalcoholic fatty liver disease in obese children and adolescents . J Ppediatr Gastroenterol Nutr, 2017, 64: 413-417.
|
| [17] |
Beserra BT, Fernandes R, do Rosario VA, et al. A systematic review and meta-analysis of the prebiotics and synbiotics effects on glycaemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity . Clin Nutr, 2015, 34: 845-858.
|
| [18] |
Woodhouse CA, Patel VC, Singanayagam A, et al. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease . Aliment Pharmacol Ther, 2018, 47: 192-202.
|
| [19] |
Cortez-Pinto H, Borralho P, Machado J, et al. Microbiota modulation with synbiotic decreases liver fibrosis in a high fat choline deficient diet mice model of non-alcoholic steatohepatitis (NASH) . GE Port J Gastroenterol, 2016, 23: 132-141.
|
| [20] |
Ferolla SM, Couto CA, Costa-Silva L, et al. Beneficial effect of synbiotic supplementation on hepatic steatosis and anthropo-metric parameters, but not on gut permeability in a population with nonalcoholic steatohepatitis . Nutrients, 2016, 8.pii:E397.
|
| [21] |
Rossen NG, MacDonald JK, de Vries EM, et al. Fecal microbiota transplantation as novel therapy in gastroenterology: a systematic review . World J Gastroenterol, 2015, 21: 5359-5371.
|
| [22] |
骆庆玲, 周永健. 粪菌移植治疗非酒精性脂肪性肝病研究与思考.实用肝脏病杂志,2017, 20: 647-650.
|
| [23] |
Zhang X, Zhao Y, Xu J, et al. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats . Sci Rep, 2015, 5:14405.
|
| [24] |
Sun L, Xie C, Wang G, et al. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin . Nat Med, 2018, 24: 1919-1929.
|
| [25] |
Wang Y, Shou JW, Li XY, et al. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism . Metabolism, 2017, 70:72-84.
|
| [26] |
Zam W. Gut microbiota as a prospective therapeutic target for curcumin: a review of mutual influence . J Nutr Metab, 2018, 2018:1367984.
|
| [27] |
Zhang Y, Tang K, Deng Y, et al. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats . Biomed Pharmacother, 2018, 102:1025-1036.
|
